• 2023
  Belkacem N, Deghmane AE, Taha MK, Biofilm formation by non-typeable Haemophilus influenzae confers resistance to complement-mediated clearance., J Infect Dis 2023 Dec; (): .
• 2023
  Taha S, Hong E, Denizon M, Falguières M, Terrade A, Deghmane AE, Taha MK, The rapid rebound of invasive meningococcal disease in France at the end of 2022., J Infect Public Health 2023 Dec; 16(12): 1954-1960.
• 2023
  Beggaz M, Guiddir T, Hong E, Deghmane AE, Taha MK, Characteristics of Meningococcal Invasive Disease in Neonates and Virulence of the Corresponding Isolates., Neonatology 2023 Jun; (): 1-7.
• 2023
  Deghmane AE, Hong E, Taha MK, Recent Evolution of Susceptibility to Beta-Lactams in Neisseria meningitidis., Antibiotics (Basel) 2023 Jun; 12(6): .
• 2022
  Taha S, Taha MK, Deghmane AE, , Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France., NPJ Vaccines 2022 Jun; 7(1): 73.
• 2020
  Biolchi A, De Angelis G, Moschioni M, Tomei S, Brunelli B, Giuliani M, Bambini S, Borrow R, Claus H, Gorla MCO, Hong E, Lemos APS, Lucidarme J, Taha MK, Vogel U, Comanducci M, Budroni S, Giuliani MM, Rappuoli R, Pizza M, Boucher P, , Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates., Vaccine 2020 Oct; (): .
• 2020
  Willerton L, Lucidarme J, Campbell H, Caugant DA, Claus H, Jacobsson S, Ladhani SN, Mölling P, Neri A, Stefanelli P, Taha MK, Vogel U, Borrow R, , Geographically widespread invasive meningococcal disease caused by a ciprofloxacin resistant non-groupable strain of the ST-175 clonal complex., J Infect 2020 Oct; 81(4): 575-584.
• 2020
  Levy M, Aouiti Trabelsi M, Taha MK, , Evidence for Multi-Organ Infection During Experimental Meningococcal Sepsis due to ST-11 Isolates in Human Transferrin-Transgenic Mice., Microorganisms 2020 Sep; 8(10): .
• 2020
  Pivette M, Taha MK, Barret AS, Polard E, Hautier MB, Dufour JB, Faisant M, King LA, Antona D, Levy-Bruhl D, Tillaut H, Scanff A, Morival C, Aranda Grau JH, Guillaumot P, Gagnière B, , Targeted vaccination campaigns of teenagers after two clusters of B invasive meningococcal disease in Brittany, France, 2017., BMC Public Health 2020 Sep; 20(1): 1382.
• 2020
  Tubiana S, Varon E, Biron C, Ploy MC, Mourvillier B, Taha MK, Revest M, Poyart C, Martin-Blondel G, Lecuit M, Cua E, Pasquet B, Preau M, Hoen B, Duval X, , , Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort., Clin Microbiol Infect 2020 Sep; 26(9): 1192-1200.
• 2020
  Feagins AR, Ronveaux O, Taha MK, Caugant DA, Smith V, Fernandez K, Glennie L, Fox LM, Wang X, , Next generation rapid diagnostic tests for meningitis diagnosis., J Infect 2020 Sep; (): .
• 2020
  Taha M-K, Deghman A-E, Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease, BMC Res Notes.
• 2020
  Tchatchouang S, Nzouankeu A, Hong E, Terrade A, Denizon M, Deghmane AE, Ndiang SMT, Pefura-Yone EW, Penlap Beng V, Njouom R, Fonkoua MC, Taha MK, , Analysis of Haemophilus species in patients with respiratory tract infections in Yaoundé, Cameroon., Int J Infect Dis 2020 Aug; 100(): 12-20.
• 2020
  Borrow R, Taha MK, Giuliani MM, Pizza M, Banzhoff A, Bekkat-Berkani R, , Methods to evaluate serogroup B meningococcal vaccines: From predictions to real-world evidence., J Infect 2020 Jul; (): .
• 2020
  Leo S, Lazarevic V, Girard M, Getaz-Jimenez Velasco GC, Gaïa N, Renzi G, Cherkaoui A, Hong E, Taha MK, Schrenzel J, , Strain coverage of Bexsero vaccine assessed by whole-genome sequencing over a cohort of invasive meningococci of serogroups B and W isolated in Switzerland., Vaccine 2020 Jul; 38(33): 5324-5331.
• 2020
  Deghmane AE, Haeghebaert S, Hong E, Jousset A, Barret AS, Taha MK, , Emergence of new genetic lineage, ST-9316, of Neisseria meningitidis group W in Hauts-de-France region, France 2013-2018., J Infect 2020 May; 80(5): 519-526.
• 2020
  Domenech de Cellès M, Campbell H, Borrow R, Taha MK, Opatowski L, , Transmissibility and pathogenicity of the emerging meningococcal serogroup W sequence type-11 complex South American strain: a mathematical modeling study., BMC Med 2020 Apr; 18(1): 109.
• 2020
  Eriksson L, Stenmark B, Deghmane AE, Thulin Hedberg S, Säll O, Fredlund H, Mölling P, Taha MK, , Difference in virulence between Neisseria meningitidis serogroups W and Y in transgenic mice., BMC Microbiol 2020 Apr; 20(1): 92.
• 2020
  Taha MK, Gaudelus J, Deghmane AE, Caron F, , Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries., Hum Vaccin Immunother 2020 Mar; (): 1-6.
• 2020
  Haddar CH, Terrade A, Verhoeven P, Njanpop-Lafourcade BM, Dosso M, Sidikou F, Mahamane AE, Lombart JP, Razki A, Hong E, Agnememel A, Begaud E, Germani Y, Pozzetto B, Taha MK, , Validation of a New Rapid Detection Test for Detection of Neisseria meningitidis A/C/W/X/Y Antigens in Cerebrospinal Fluid., J Clin Microbiol 2020 02; 58(3): .
• 2020
  Williams AH, Wheeler R, Deghmane AE, Santecchia I, Schaub RE, Hicham S, Moya Nilges M, Malosse C, Chamot-Rooke J, Haouz A, Dillard JP, Robins WP, Taha MK, Gomperts Boneca I, Defective lytic transglycosylase disrupts cell morphogenesis by hindering cell wall de-O-acetylation in Neisseria meningitidis., Elife 2020 Feb; 9(): .
• 2020
  Topaz N, Caugant DA, Taha MK, Brynildsrud OB, Debech N, Hong E, Deghmane AE, Ouédraogo R, Ousmane S, Gamougame K, Njanpop-Lafourcade BM, Diarra S, Fox LM, Wang X, , Corrigendum to “Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011-2016” EBioMedicine 41 (2019) 488-496., EBioMedicine 2020 01; 51(): 102564.
• 2019
  Deghmane AE, Hong E, Chehboub S, Terrade A, Falguières M, Sort M, Harrison O, Jolley KA, Taha MK, , High diversity of invasive Haemophilus influenzae isolates in France and the emergence of resistance to third generation cephalosporins by alteration of ftsI gene., J Infect 2019 07; 79(1): 7-14.
• 2019
  Topaz N, Caugant DA, Taha MK, Brynildsrud OB, Debech N, Hong E, Deghmane AE, Ouédraogo R, Ousmane S, Gamougame K, Njanpop-Lafourcade BM, Diarra S, Fox LM, Wang X, , Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011-2016., EBioMedicine 2019 Mar; 41(): 488-496.
• 2019
  Muzzi A, Brozzi A, Serino L, Bodini M, Abad R, Caugant D, Comanducci M, Lemos AP, Gorla MC, Křížová P, Mikula C, Mulhall R, Nissen M, Nohynek H, Simões MJ, Skoczyńska A, Stefanelli P, Taha MK, Toropainen M, Tzanakaki G, Vadivelu-Pechai K, Watson P, Vazquez JA, Rajam G, Rappuoli R, Borrow R, Medini D, , Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide., Vaccine 2019 02; 37(7): 991-1000.
• 2019
  Taha MK, Deghmane AE, Knol M, van der Ende A, Whole genome sequencing reveals Trans-European spread of an epidemic Neisseria meningitidis serogroup W clone, Clin. Microbiol. Infect. 2019 Jan;.
• 2019
  Deghmane AE, Hong E, Taha MK, , Diagnosis of Meningococcal Infection Using Internally Controlled Multiplex Real-Time PCR., Methods Mol Biol 2019 ; 1969(): 17-31.
• 2018
  Sevestre J, Diene SM, Aouiti-Trabelsi M, Deghmane AE, Tournier I, François P, Caron F, Taha MK, , Differential expression of hemoglobin receptor, HmbR, between carriage and invasive isolates of Neisseria meningitidis contributes to virulence: lessons from a clonal outbreak., Virulence 2018 Dec; 9(1): 923-929.
• 2018
  Kesanopoulos K, Bratcher HB, Hong E, Xirogianni A, Papandreou A, Taha MK, Maiden MCJ, Tzanakaki G, Characterization of meningococcal carriage isolates from Greece by whole genome sequencing: Implications for 4CMenB vaccine implementation, PLoS ONE 2018;13(12):e0209919.
• 2018
  Acevedo R, Bai X, Borrow R, Caugant DA, Carlos J, Ceyhan M, Christensen H, Climent Y, De Wals P, Dinleyici EC, Echaniz-Aviles G, Hakawi A, Kamiya H, Karachaliou A, Lucidarme J, Meiring S, Mironov K, Sáfadi MAP, Shao Z, Smith V, Steffen R, Stenmark B, Taha MK, Trotter C, Vázquez JA, Zhu B, , The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations., Expert Rev Vaccines 2019 01; 18(1): 15-30.
• 2018
  Frank T, Hong E, Mbecko JR, Lombart JP, Taha MK, Rubbo PA, Emergence of Neisseria meningitidis Serogroup W, Central African Republic, 2015-2016, Emerging Infect. Dis. 2018 11;24(11):2080-2083.
• 2018
  Hong E, Bakhalek Y, Taha MK, Identification of Neisseria meningitidis by MALDI-TOF MS may not be reliable, Clin. Microbiol. Infect. 2018 Oct;.
• 2018
  Gaschignard J, Hassani N, El Sissy C, Bonacorsi S, Dauger S, Chomton M, Taha MK, Levy M, , Delayed Generalized Necrotic Purpuric Rash in a C6-deficient 12-year-old Girl Treated for Group W Meningococcal Disease., Pediatr Infect Dis J 2018 10; 37(10): 1014-1015.
• 2018
  Guiddir T, Gros M, Hong E, Terrade A, Denizon M, Deghmane AE, Taha MK, , Unusual Initial Abdominal Presentations of Invasive Meningococcal Disease., Clin Infect Dis 2018 09; 67(8): 1220-1227.
• 2018
  Hong E, Deghmane AE, Taha MK, , Acquisition of Beta-Lactamase by Neisseria meningitidis through Possible Horizontal Gene Transfer., Antimicrob Agents Chemother 2018 09; 62(9): .
• 2018
  Levy M, Deghmane AE, Aouiti-Trabelsi M, Dauger S, Faye A, Mariani-Kurkdjian P, Taha MK, , Analysis of the impact of corticosteroids adjuvant treatment during experimental invasive meningococcal infection in mice., Steroids 2018 Aug; 136(): 32-39.
• 2018
  Thabuis A, Tararbit K, Taha MK, Dejour-Salamanca D, Ronin V, Parent du Chatelet I, Spaccaferri G, , Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination., Euro Surveill 2018 07; 23(28): .
• 2018
  Razki A, Hong E, Zerouali K, Belabbes H, Aitmouss K, Terrade A, Zaki B, Deghmane AE, Elmdaghri N, Taha MK, , Molecular Characterization of Invasive Isolates of Neisseria meningitidis in Casablanca, Morocco., J Clin Microbiol 2018 07; 56(7): .
• 2018
  Lesourd A, Magne N, Soares A, Lemaitre C, Taha MK, Gueit I, Wolff M, Caron F, , Primary bacterial ventriculitis in adults, an emergent diagnosis challenge: report of a meningoccal case and review of the literature., BMC Infect Dis 2018 05; 18(1): 226.
• 2018
  Bratcher HB, Brehony C, Heuberger S, Pieridou-Bagatzouni D, Křížová P, Hoffmann S, Toropainen M, Taha MK, Claus H, Tzanakaki G, Erdôsi T, Galajeva J, van der Ende A, Skoczyńska A, Pana M, Vaculíková A, Paragi M, Maiden MC, Caugant DA, Establishment of the European meningococcal strain collection genome library (EMSC-GL) for the 2011 to 2012 epidemiological year, Euro Surveill. 2018 May;23(20).
• 2018
  Belkacem N, Bourdet-Sicard R, Taha MK, Lactobacillus paracasei feeding improves the control of secondary experimental meningococcal infection in flu-infected mice, BMC Infect. Dis. 2018 04;18(1):167.
• 2018
  McNeil LK, Donald RGK, Gribenko A, French R, Lambert N, Harris SL, Jones TR, Li S, Zlotnick G, Vogel U, Claus H, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Wang X, Vuong J, Mayer LW, Pride MW, Jansen KU, Anderson AS, , Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine., mBio 2018 03; 9(2): .
• 2018
  Williams AH, Wheeler R, Rateau L, Malosse C, Chamot-Rooke J, Haouz A, Taha MK, Boneca IG, , A step-by-step in crystallo guide to bond cleavage and 1,6-anhydro-sugar product synthesis by a peptidoglycan-degrading lytic transglycosylase., J Biol Chem 2018 04; 293(16): 6000-6010.
• 2018
  Li J, Shao Z, Liu G, Bai X, Borrow R, Chen M, Guo Q, Han Y, Li Y, Taha MK, Xu X, Xu X, Zheng H, Meningococcal disease and control in China: Findings and updates from the Global Meningococcal Initiative (GMI), J. Infect. 2018 May;76(5):429-437.
• 2018
  Shirley M, Taha MK, , MenB-FHbp Meningococcal Group B Vaccine (Trumenba®): A Review in Active Immunization in Individuals Aged ≥ 10 Years., Drugs 2018 Feb; 78(2): 257-268.
• 2018
  Hong E, Barret AS, Terrade A, Denizon M, Antona D, Aouiti-Trabelsi M, Deghmane AE, Parent du Châtelet I, Levy-Bruhl D, Taha MK, , Clonal replacement and expansion among invasive meningococcal isolates of serogroup W in France., J Infect 2018 Feb; 76(2): 149-158.
• 2017
  Belkacem N, Serafini N, Wheeler R, Derrien M, Boucinha L, Couesnon A, Cerf-Bensussan N, Gomperts Boneca I, Di Santo JP, Taha MK, Bourdet-Sicard R, , Lactobacillus paracasei feeding improves immune control of influenza infection in mice., PLoS One 2017 ; 12(9): e0184976.
• 2017
  Cheddani H, Desgabriel AL, Coffin E, Taha MK, Verdet C, Bachmeyer C, Flejou JF, Amiot X, No Neck Pain: Meningococcemia, Am. J. Med. 2018 Jan;131(1):37-40.
• 2017
  Dick J, Hebling S, Becam J, Taha MK, Schubert-Unkmeir A, , Comparison of the inflammatory response of brain microvascular and peripheral endothelial cells following infection with Neisseria meningitidis., Pathog Dis 2017 07; 75(5): .
• 2017
  Bassi C, Taha MK, Merle C, Hong E, Lévy-Bruhl D, Barret AS, Mounchetrou Njoya I, , A cluster of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup W among university students, France, February to May 2017., Euro Surveill 2017 Jul; 22(28): .
• 2017
  Sevestre J, Hong E, Delbos V, Terrade A, Mallet E, Deghmane AE, Lemée L, Taha MK, Caron F, , Durability of immunogenicity and strain coverage of MenBvac, a meningococcal vaccine based on outer membrane vesicles: Lessons of the Normandy campaign., Vaccine 2017 07; 35(32): 4029-4033.
• 2017
  Narni-Mancinelli E, Gauthier L, Baratin M, Guia S, Fenis A, Deghmane AE, Rossi B, Fourquet P, Escalière B, Kerdiles YM, Ugolini S, Taha MK, Vivier E, , Complement factor P is a ligand for the natural killer cell-activating receptor NKp46., Sci Immunol 2017 Apr; 2(10): .
• 2017
  Borrow R, Caugant DA, Ceyhan M, Christensen H, Dinleyici EC, Findlow J, Glennie L, Von Gottberg A, Kechrid A, Vázquez Moreno J, Razki A, Smith V, Taha MK, Tali-Maamar H, Zerouali K, , , Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative., J Infect 2017 07; 75(1): 1-11.
• 2017
  Rosain J, Hong E, Fieschi C, Martins PV, El Sissy C, Deghmane AE, Ouachée M, Thomas C, Launay D, de Pontual L, Suarez F, Moshous D, Picard C, Taha MK, Frémeaux-Bacchi V, , Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies., J Infect Dis 2017 04; 215(8): 1331-1338.
• 2017
  Whittaker R, Dias JG, Ramliden M, Ködmön C, Economopoulou A, Beer N, Pastore Celentano L, , The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014, Vaccine 2017 04;35(16):2034-2041.
• 2017
  Parent du Chatelet I, Deghmane AE, Antona D, Hong E, Fonteneau L, Taha MK, Lévy-Bruhl D, Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015, J. Infect. 2017 06;74(6):564-574.
• 2017
  Williams AH, Wheeler R, Thiriau C, Haouz A, Taha MK, Boneca IG, , Bulgecin A: The Key to a Broad-Spectrum Inhibitor  That Targets Lytic Transglycosylases., Antibiotics (Basel) 2017 Feb; 6(1): .
• 2017
  Taha MK, Hawkins JC, Liberator P, Deghmane AE, Andrew L, Hao L, Jones TR, McNeil LK, O'Neill RE, Perez JL, Jansen KU, Anderson AS, , Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France., Vaccine 2017 03; 35(11): 1530-1537.
• 2016
  Rasoanandrasana S, Raberahona M, Milenkov M, Rakotomahefa Narison ML, Ranaivo Rabetokotany F, Rakotovao L, Randria MJD, Hong E, Paranhos-Baccalà G, Taha MK, Rakoto-Andrianarivelo M, , Resurgence of Neisseria meningitidis serogroup W ST-11 (cc11) in Madagascar, 2015-2016., Int J Infect Dis 2017 Feb; 55(): 1-3.
• 2016
  Borrow R, Alarcón P, Carlos J, Caugant DA, Christensen H, Debbag R, De Wals P, Echániz-Aviles G, Findlow J, Head C, Holt D, Kamiya H, Saha SK, Sidorenko S, Taha MK, Trotter C, Vázquez Moreno JA, von Gottberg A, Sáfadi MA, , , The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection., Expert Rev Vaccines 2017 04; 16(4): 313-328.
• 2016
  Hong E, Terrade A, Taha MK, , Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine., Hum Vaccin Immunother 2017 03; 13(3): 645-648.
• 2016
  Bilal A, Taha MK, Caeymaex L, Cohen R, Levy C, Durrmeyer X, , , Neonatal Meningococcal Meningitis In France From 2001 To 2013, Pediatr. Infect. Dis. J. 2016 11;35(11):1270-1272.
• 2016
  Borrow R, Lee JS, Vázquez JA, Enwere G, Taha MK, Kamiya H, Kim HM, Jo DS, , , Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal Initiative., Vaccine 2016 11; 34(48): 5855-5862.
• 2016
  Deghmane AE, Hong E, Taha MK, , Emergence of meningococci with reduced susceptibility to third-generation cephalosporins., J Antimicrob Chemother 2017 01; 72(1): 95-98.
• 2016
  Kretz CB, Retchless AC, Sidikou F, Issaka B, Ousmane S, Schwartz S, Tate AH, Pana A, Njanpop-Lafourcade BM, Nzeyimana I, Nse RO, Deghmane AE, Hong E, Brynildsrud OB, Novak RT, Meyer SA, Oukem-Boyer OOM, Ronveaux O, Caugant DA, Taha MK, Wang X, , Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015, Emerging Infect. Dis. 2016 10;22(10):1762-1768.
• 2016
  Zapun A, Morlot C, Taha MK, , Resistance to β-Lactams in Neisseria ssp Due to Chromosomally Encoded Penicillin-Binding Proteins., Antibiotics (Basel) 2016 Sep; 5(4): .
• 2016
  Antunes A, Derkaoui M, Terrade A, Denizon M, Deghmane AE, Deutscher J, Delany I, Taha MK, , The Phosphocarrier Protein HPr Contributes to Meningococcal Survival during Infection., PLoS One ; 11(9): e0162434.
• 2016
  Sidikou F, Zaneidou M, Alkassoum I, Schwartz S, Issaka B, Obama R, Lingani C, Tate A, Ake F, Sakande S, Ousmane S, Zanguina J, Seidou I, Nzeyimana I, Mounkoro D, Abodji O, Wang X, Taha MK, Moulia-Pelat JP, Pana A, Kadade G, Ronveaux O, Novak R, Oukem-Boyer OOM, Meyer S, , , Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data., Lancet Infect Dis 2016 Nov; 16(11): 1288-1294.
• 2016
  Saguer A, Smaoui H, Taha MK, Kechrid A, Characterization of invasive Neisseria meningitidis strains isolated at the Children’s Hospital of Tunis, Tunisia, East. Mediterr. Health J. 2016 Aug;22(5):343-9.
• 2016
  Derkaoui M, Antunes A, Nait Abdallah J, Poncet S, Mazé A, Ma Pham QM, Mokhtari A, Deghmane AE, Joyet P, Taha MK, Deutscher J, Transport and Catabolism of Carbohydrates by Neisseria meningitidis, J. Mol. Microbiol. Biotechnol. 2016;26(5):320-32.
• 2016
  Vázquez JA, Taha MK, Findlow J, Gupta S, Borrow R, Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease, Epidemiol. Infect. 2016 10;144(14):3052-3057.
• 2016
  Belkacem N, Hong E, Antunes A, Terrade A, Deghmane AE, Taha MK, , Use of Animal Models To Support Revising Meningococcal Breakpoints of β-Lactams., Antimicrob Agents Chemother 2016 07; 60(7): 4023-7.
• 2016
  Taha MK, Claus H, Lappann M, Veyrier FJ, Otto A, Becher D, Deghmane AE, Frosch M, Hellenbrand W, Hong E, Parent du Châtelet I, Prior K, Harmsen D, Vogel U, , Evolutionary Events Associated with an Outbreak of Meningococcal Disease in Men Who Have Sex with Men., PLoS One 2016 ; 11(5): e0154047.
• 2016
  Agnememel A, Hong E, Giorgini D, Nuñez-Samudio V, Deghmane AE, Taha MK, Neisseria meningitidis Serogroup X in Sub-Saharan Africa, Emerging Infect. Dis. 2016 Apr;22(4):698-702.
• 2016
  Lecocq H, Parent du Châtelet I, Taha MK, Lévy-Bruhl D, Dervaux B, , Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France., Vaccine 2016 Apr; 34(19): 2240-50.
• 2016
  Derkaoui M, Antunes A, Poncet S, Nait Abdallah J, Joyet P, Mazé A, Henry C, Taha MK, Deutscher J, Deghmane AE, , The phosphocarrier protein HPr of Neisseria meningitidis interacts with the transcription regulator CrgA and its deletion affects capsule production, cell adhesion, and virulence., Mol Microbiol 2016 06; 100(5): 788-807.
• 2015
  Waśko I, Hong E, De Paola R, Stella M, Moschioni M, Taha MK, Skoczyńska A, High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland, Vaccine 2016 Jan;34(4):510-515.
• 2015
  Sáfadi MA, O'Ryan M, Valenzuela Bravo MT, Brandileone MC, Gorla MC, de Lemos AP, Moreno G, Vazquez JA, López EL, Taha MK, Borrow R, , , The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations., Vaccine 2015 Nov; 33(48): 6529-36.
• 2015
  Sridhar S, Greenwood B, Head C, Plotkin SA, Sáfadi MA, Saha S, Taha MK, Tomori O, Gessner BD, , Global incidence of serogroup B invasive meningococcal disease: a systematic review., Lancet Infect Dis 2015 Nov; 15(11): 1334-46.
• 2015
  Matar R, Hong E, Levy C, Guillot M, Cohen R, Taha MK, Madhi F, , Vaccine Failure After Meningococcal C Conjugate Vaccine May Be Linked to Decline of Bactericidal Titers and Absence of Herd Immunity., Pediatr Infect Dis J 2015 Oct; 34(10): 1142-3.
• 2015
  Besbes A, Le Goff S, Antunes A, Terrade A, Hong E, Giorgini D, Taha MK, Deghmane AE, , Hyperinvasive Meningococci Induce Intra-nuclear Cleavage of the NF-κB Protein p65/RelA by Meningococcal IgA Protease., PLoS Pathog 2015 Aug; 11(8): e1005078.
• 2015
  Lucidarme J, Hill DM, Bratcher HB, Gray SJ, du Plessis M, Tsang RS, Vazquez JA, Taha MK, Ceyhan M, Efron AM, Gorla MC, Findlow J, Jolley KA, Maiden MC, Borrow R, , Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage., J Infect 2015 Nov; 71(5): 544-52.
• 2015
  Veyrier FJ, Biais N, Morales P, Belkacem N, Guilhen C, Ranjeva S, Sismeiro O, Péhau-Arnaudet G, Rocha EP, Werts C, Taha MK, Boneca IG, , Common Cell Shape Evolution of Two Nasopharyngeal Pathogens., PLoS Genet 2015 Jul; 11(7): e1005338.
• 2015
  Levy M, Antunes A, Fiette L, Deghmane AE, Taha MK, , Impact of corticosteroids on experimental meningococcal sepsis in mice., Steroids 2015 Sep; 101(): 96-102.
• 2015
  Wyplosz B, Derradji O, Hong E, François H, Durrbach A, Duclos-Vallée JC, Samuel D, Escaut L, Launay O, Vittecoq D, Taha MK, Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients, Transpl Infect Dis 2015 Apr;17(2):322-7.
• 2015
  Tsang RS, Hoang L, Tyrrell G, Horsman G, Wylie J, Jamieson FB, Lefebvre B, Taha MK, , Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013., J Med Microbiol 2015 Feb; 64(Pt 2): 174-9.
• 2015
  Aubert L, Taha M, Boo N, Le Strat Y, Deghmane AE, Sanna A, Barret AS, Lévy-Bruhl D, Vandentorren S, Parent du Châtelet I, Serogroup C invasive meningococcal disease among men who have sex with men and in gay-oriented social venues in the Paris region: July 2013 to December 2014, Euro Surveill. 2015 Jan;20(3).
• 2015
  Tsang RS, Hoang L, Tyrrell G, Horsman G, Wylie J, Jamieson FB, Lefebvre B, Taha MK, Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post MenC-conjugate vaccine era, 2009-2013, J. Med. Microbiol. 2015 Jan;.
• 2015
  Bröker M, Emonet S, Fazio C, Jacobsson S, Koliou M, Kuusi M, Pace D, Paragi M, Pysik A, Simões MJ, Skoczynska A, Stefanelli P, Toropainen M, Taha MK, Tzanakaki G, Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013, Hum Vaccin Immunother 2015;11(9):2281-6.
• 2014
  de Marcellus C, Taha MK, Gaudelus J, Fremeaux-Bacchi V, de Pontual L, Guiddir T, [Complement terminal fraction deficiency revealed at first invasive meningococcal infection], Arch Pediatr 2015 Mar;22(3):296-9.
• 2014
  Agnememel A, Traincard F, Dartevelle S, Mulard L, Mahamane AE, Oukem-Boyer OO, Denizon M, Kacou-N Douba A, Dosso M, Gake B, Lombart JP, Taha MK, , Development and evaluation of a dipstick diagnostic test for Neisseria meningitidis serogroup X., J Clin Microbiol 2015 Feb; 53(2): 449-54.
• 2014
  Biville F, Brézillon C, Giorgini D, Taha MK, , Pyrophosphate-mediated iron acquisition from transferrin in Neisseria meningitidis does not require TonB activity., PLoS One 2014 ; 9(10): e107612.
• 2014
  Williams AH, Veyrier FJ, Bonis M, Michaud Y, Raynal B, Taha MK, White SW, Haouz A, Boneca IG, , Visualization of a substrate-induced productive conformation of the catalytic triad of the Neisseria meningitidis peptidoglycan O-acetylesterase reveals mechanistic conservation in SGNH esterase family members., Acta Crystallogr D Biol Crystallogr 2014 Oct; 70(Pt 10): 2631-9.
• 2014
  Lemée L, Hong E, Etienne M, Deghmane AE, Delbos V, Terrade A, Berthelot G, Caron F, Taha MK, , Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis., PLoS One 2014 ; 9(9): e107240.
• 2014
  Taha MK, Deghmane AE, , Meningococcal carriage: the dilemma of 4CMenB vaccine., Lancet 2014 Dec; 384(9960): 2088-90.
• 2014
  Levy C, Varon E, Taha MK, Béchet S, Bonacorsi S, Cohen R, Bingen E, [Changes in bacterial meningitis in French children resulting from vaccination], Arch Pediatr 2014 Jul;21(7):736-44.
• 2014
  Guiddir T, Deghmane AE, Giorgini D, Taha MK, , Lipocalin 2 in cerebrospinal fluid as a marker of acute bacterial meningitis., BMC Infect Dis 2014 May; 14(): 276.
• 2014
  Tzanakaki G, Hong E, Kesanopoulos K, Xirogianni A, Bambini S, Orlandi L, Comanducci M, Muzzi A, Taha MK, Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine, BMC Microbiol. 2014 Apr;14:111.
• 2014
  Brehony C, Trotter CL, Ramsay ME, Chandra M, Jolley KA, van der Ende A, Carion F, Berthelsen L, Hoffmann S, Harðardóttir H, Vazquez JA, Murphy K, Toropainen M, Caniça M, Ferreira E, Diggle M, Edwards GF, Taha MK, Stefanelli P, Kriz P, Gray SJ, Fox AJ, Jacobsson S, Claus H, Vogel U, Tzanakaki G, Heuberger S, Caugant DA, Frosch M, Maiden MC, Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development, Clin. Vaccine Immunol. 2014 Jun;21(6):847-53.
• 2014
  Bröker M, Bukovski S, Culic D, Jacobsson S, Koliou M, Kuusi M, Simões MJ, Skoczynska A, Toropainen M, Taha MK, Tzanakaki G, Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012, Hum Vaccin Immunother 2014;10(6):1725-8.
• 2014
  Madhi F, Levy C, Deghmane AE, Béchet S, Cohen R, , , Taha MK, [Impact of corticosteroids in the immediate management of invasive meningococcal disease associated with hyperinvasive strains of the ST-11 clonal complex in children], Arch Pediatr 2014 Mar;21(3):258-64.
• 2013
  Guilhen C, Taha MK, Veyrier FJ, , Role of transition metal exporters in virulence: the example of Neisseria meningitidis., Front Cell Infect Microbiol 2013 ; 3(): 102.
• 2013
  Collard JM, Issaka B, Zaneidou M, Hugonnet S, Nicolas P, Taha MK, Greenwood B, Jusot JF, Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination., BMC Infect Dis 2013 Dec; 13(): 576.
• 2013
  Veyrier FJ, Hong E, Deghmane AE, Taha MK, , Draft Genome Sequence of a Neisseria meningitidis Serogroup C Isolate of Sequence Type 11 Linked to an Outbreak among Men Who Have Sex with Men., Genome Announc 2013 Oct; 1(5): .
• 2013
  Hoiseth SK, Murphy E, Andrew L, Vogel U, Frosch M, Hellenbrand W, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Mayer LW, Wang X, Macneil JR, York L, Tan CY, Jansen KU, Anderson AS, , A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups., Pediatr Infect Dis J 2013 Oct; 32(10): 1096-101.
• 2013
  Taha MK, Immunisation against meningococcus B, Lancet 2013 Sep;382(9896):936.
• 2013
  Delbos V, Lemée L, Bénichou J, Berthelot G, Deghmane AE, Leroy JP, Houivet E, Hong E, Taha MK, Caron F, , Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage, Vaccine 2013 Sep;31(40):4416-20.
• 2013
  Njanpop-Lafourcade BM, Hugonnet S, Djogbe H, Kodjo A, N'douba AK, Taha MK, Stoeckel P, Gessner BD, Mobile microbiological laboratory support for evaluation of a meningitis epidemic in Northern Benin, PLoS ONE 2013;8(7):e68401.
• 2013
  Terrade A, Collard JM, Nato F, Taha MK, Laboratory evaluation of a rapid diagnostic test for Neisseria meningitidis serogroup A., Trans R Soc Trop Med Hyg 2013 Jul; 107(7): 460-1.
• 2013
  Gaschignard J, Levy C, Deghmane AE, Dubos F, Muszlak M, Cohen R, Bingen E, Faye A, Taha MK, Invasive serogroup w meningococcal disease in children: a national survey from 2001 to 2008 in France, Pediatr. Infect. Dis. J. 2013 Jul;32(7):798-800.
• 2013
  Zarantonelli ML, Skoczynska A, Antignac A, El Ghachi M, Deghmane AE, Szatanik M, Mulet C, Werts C, Peduto L, d'Andon MF, Thouron F, Nato F, Lebourhis L, Philpott DJ, Girardin SE, Vives FL, Sansonetti P, Eberl G, Pedron T, Taha MK, Boneca IG, , Penicillin resistance compromises Nod1-dependent proinflammatory activity and virulence fitness of neisseria meningitidis., Cell Host Microbe 2013 Jun; 13(6): 735-45.
• 2013
  Delbos V, Lemée L, Bénichou J, Berthelot G, Taha MK, Caron F, , Meningococcal carriage during a clonal meningococcal B outbreak in France, Eur. J. Clin. Microbiol. Infect. Dis. 2013 Nov;32(11):1451-9.
• 2013
  Taha MK, Kacou-N'douba A, Hong E, Deghmane AE, Giorgini D, Okpo SL, Kangah T, Dosso M, Travel-related Neisseria meningitidis serogroup W135 infection, France, Emerging Infect. Dis. 2013 Jun;19(6):1030-2.
• 2013
  Toubiana J, Heilbronner C, Gitiaux C, Oualha M, Taha MK, Rousseau C, Picard C, Mira JP, Gendrel D, Pachymeningitis after meningococcal infection, Lancet 2013 May;381(9877):1596.
• 2013
  Madhi F, Levy C, Deghmane AE, Béchet S, Cohen R, Taha MK, , , Corticosteroid therapy in genotype ST-11 meningococcal infections, Pediatr. Infect. Dis. J. 2013 Mar;32(3):291-3.
• 2013
  Delaune D, Andriamanantena D, Mérens A, Viant E, Aoun O, Ceppa F, Taha MK, Rapp C, Management of a rifampicin-resistant meningococcal infection in a teenager, Infection 2013 Jun;41(3):705-8.
• 2013
  Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, Bambini S, Carannante A, Deghmane AE, Fazio C, Frosch M, Frosi G, Gilchrist S, Giuliani MM, Hong E, Ledroit M, Lovaglio PG, Lucidarme J, Musilek M, Muzzi A, Oksnes J, Rigat F, Orlandi L, Stella M, Thompson D, Pizza M, Rappuoli R, Serruto D, Comanducci M, Boccadifuoco G, Donnelly JJ, Medini D, Borrow R, Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis 2013 May;13(5):416-25.
• 2013
  Veyrier FJ, Williams AH, Mesnage S, Schmitt C, Taha MK, Boneca IG, , De-O-acetylation of peptidoglycan regulates glycan chain extension and affects in vivo survival of Neisseria meningitidis., Mol Microbiol 2013 Mar; 87(5): 1100-12.
• 2013
  Hong E, Thulin Hedberg S, Abad R, Fazio C, Enríquez R, Deghmane AE, Jolley KA, Stefanelli P, Unemo M, Vazquez JA, Veyrier FJ, Taha MK, , Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin., Antimicrob Agents Chemother 2013 Apr; 57(4): 1961-4.
• 2012
  Mechergui A, Achour W, Giorgini D, Baaboura R, Taha MK, Hassen AB, Molecular typing of Neisseria perflava clinical isolates, APMIS 2013 Sep;121(9):843-7.
• 2012
  Hong E, Giuliani MM, Deghmane AE, Comanducci M, Brunelli B, Dull P, Pizza M, Taha MK, , Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?, Vaccine 2013 Feb; 31(7): 1113-6.
• 2012
  Hong E, Giorgini D, Deghmane AE, Taha MK, , Functional impacts of the diversity of the meningococcal factor H binding protein., Vaccine 2012 Dec; 31(1): 183-9.
• 2012
  Bröker M, Jacobsson S, Kuusi M, Pace D, Simões MJ, Skoczynska A, Taha MK, Toropainen M, Tzanakaki G, Meningococcal serogroup Y emergence in Europe: update 2011, Hum Vaccin Immunother 2012 Dec;8(12):1907-11.
• 2012
  Caugant DA, Kristiansen PA, Wang X, Mayer LW, Taha MK, Ouédraogo R, Kandolo D, Bougoudogo F, Sow S, Bonte L, Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine, PLoS ONE 2012;7(9):e46019.
• 2012
  Levy C, Taha MK, Bingen E, Cohen R, , [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results], Arch Pediatr 2012 Sep;19 Suppl 2:S49-54.
• 2012
  Mounchetrou Njoya I, Deghmane A, Taha M, Isnard H, Parent du Chatelet I, A cluster of meningococcal disease caused by rifampicin-resistant C meningococci in France, April 2012, Euro Surveill. 2012 Aug;17(34).
• 2012
  Plikaytis BD, Stella M, Boccadifuoco G, DeTora LM, Agnusdei M, Santini L, Brunelli B, Orlandi L, Simmini I, Giuliani M, Ledroit M, Hong E, Taha MK, Ellie K, Rajam G, Carlone GM, Claus H, Vogel U, Borrow R, Findlow J, Gilchrist S, Stefanelli P, Fazio C, Carannante A, Oksnes J, Fritzsønn E, Klem AM, Caugant DA, Abad R, Vázquez JA, Rappuoli R, Pizza M, Donnelly JJ, Medini D, Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines, Clin. Vaccine Immunol. 2012 Oct;19(10):1609-17.
• 2012
  Caron F, Delbos V, Houivet E, Deghmane AE, Leroy JP, Hong E, Bénichou J, Taha MK, Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac, Vaccine 2012 Jul;30(34):5059-62.
• 2012
  Vogel U, Stefanelli P, Vazquez J, Taha MK, Claus H, Donnelly J, The use of vaccine antigen characterization, for example by MATS, to guide the introduction of meningococcus B vaccines, Vaccine 2012 May;30 Suppl 2:B73-7.
• 2012
  Parent du Chatelet I, Barboza P, Taha MK, W135 invasive meningococcal infections imported from Sub-Saharan Africa to France, January to April 2012, Euro Surveill. 2012 May;17(21).
• 2012
  Taha MK, Deghmane AE, , Vaccines targeting serogroup B meningococci., Lancet Infect Dis 2012 Aug; 12(8): 578-9.
• 2012
  Bröker M, Jacobsson S, DeTora L, Pace D, Taha MK, Increase of meningococcal serogroup Y cases in Europe: a reason for concern?, Hum Vaccin Immunother 2012 May;8(5):685-8.
• 2012
  Dupin N, Lecuyer H, Carlotti A, Poyart C, Coureuil M, Chanal J, Schmitt A, Vacher-Lavenu MC, Taha MK, Nassif X, Morand PC, Chronic meningococcemia cutaneous lesions involve meningococcal perivascular invasion through the remodeling of endothelial barriers, Clin. Infect. Dis. 2012 Apr;54(8):1162-5.
• 2012
  Hong E, Barraud O, Bidet P, Bingen E, Blondiaux N, Bonacorsi S, Burucoa C, Carrer A, Fortineau N, Couetdic G, Courcol R, Garnier F, Hery-Arnaud G, Lanotte P, Le Bars H, Legrand-Quillien MC, Lemée L, Mereghetti L, Millardet C, Minet J, Plouzeau-Jayle C, Pons JL, Schneider J, Taha MK, , Proficiency of PCR in hospital settings for nonculture diagnosis of invasive meningococcal infections., Clin Lab 2012 ; 58(3-4): 343-6.
• 2011
  Deghmane AE, El Kafsi H, Giorgini D, Abaza A, Taha MK, , Late repression of NF-κB activity by invasive but not non-invasive meningococcal isolates is required to display apoptosis of epithelial cells., PLoS Pathog 2011 Dec; 7(12): e1002403.
• 2011
  Hill M, Deghmane AE, Segovia M, Zarantonelli ML, Tilly G, Blancou P, Bériou G, Josien R, Anegon I, Hong E, Ruckly C, Antignac A, El Ghachi M, Boneca IG, Taha MK, Cuturi MC, Penicillin binding proteins as danger signals: meningococcal penicillin binding protein 2 activates dendritic cells through Toll-like receptor 4, PLoS ONE 2011;6(10):e23995.
• 2011
  Taha MK, Deghmane AE, , Immediate outcomes of bacterial meningitis in childhood may benefit from slow initial β-lactam infusion and oral paracetamol., Future Microbiol 2011 Oct; 6(10): 1125-9.
• 2011
  Veyrier FJ, Boneca IG, Cellier MF, Taha MK, , A novel metal transporter mediating manganese export (MntX) regulates the Mn to Fe intracellular ratio and Neisseria meningitidis virulence., PLoS Pathog 2011 Sep; 7(9): e1002261.
• 2011
  Basmaci R, Mariani P, Delacroix G, Azib S, Faye A, Taha MK, Bingen E, Bonacorsi S, Romero JR, Rotbart HA, Nyquist AC, Nolte FS, Enteroviral meningitis does not exclude concurrent bacterial meningitis, J. Clin. Microbiol. 2011 Sep;49(9):3442-3.
• 2011
  Szatanik M, Hong E, Ruckly C, Ledroit M, Giorgini D, Jopek K, Nicola MA, Deghmane AE, Taha MK, , Experimental meningococcal sepsis in congenic transgenic mice expressing human transferrin., PLoS One 2011 ; 6(7): e22210.
• 2011
  Harrison OB, Brueggemann AB, Caugant DA, van der Ende A, Frosch M, Gray S, Heuberger S, Krizova P, Olcen P, Slack M, Taha MK, Maiden MCJ, , Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review., Microbiology (Reading) 2011 Aug; 157(Pt 8): 2181-2195.
• 2011
  Caron F, du Châtelet IP, Leroy JP, Ruckly C, Blanchard M, Bohic N, Massy N, Morer I, Floret D, Delbos V, Hong E, Révillion M, Berthelot G, Lemée L, Deghmane AE, Bénichou J, Lévy-Bruhl D, Taha MK, From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak, Lancet Infect Dis 2011 Jun;11(6):455-63.
• 2011
  Harrison LH, Pelton SI, Wilder-Smith A, Holst J, Safadi MA, Vazquez JA, Taha MK, LaForce FM, von Gottberg A, Borrow R, Plotkin SA, The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease, Vaccine 2011 Apr;29(18):3363-71.
• 2010
  Delisle E, Larrieu S, Simões J, Laylle N, De Pommerol M, Taha MK, Termignon JL, Parent du Châtelet I, Community outbreak of group B meningococcal disease in southwest France–December 2008 to September 2009, Euro Surveill. 2010 Sep;15(37).
• 2010
  Deghmane AE, Parent du Chatelet I, Szatanik M, Hong E, Ruckly C, Giorgini D, Lévy-Bruhl D, Alonso JM, Taha MK, , Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France., J Infect Dis 2010 Jul; 202(2): 247-50.
• 2010
  Taha MK, Hedberg ST, Szatanik M, Hong E, Ruckly C, Abad R, Bertrand S, Carion F, Claus H, Corso A, Enríquez R, Heuberger S, Hryniewicz W, Jolley KA, Kriz P, Mollerach M, Musilek M, Neri A, Olcén P, Pana M, Skoczynska A, Sorhouet Pereira C, Stefanelli P, Tzanakaki G, Unemo M, Vázquez JA, Vogel U, Wasko I, , Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing., Antimicrob Agents Chemother 2010 Sep; 54(9): 3651-8.
• 2010
  Levy C, Taha MK, Weil Olivier C, Quinet B, Lecuyer A, Alonso JM, Aujard Y, Bingen E, Cohen R, , Association of meningococcal phenotypes and genotypes with clinical characteristics and mortality of meningitis in children, Pediatr. Infect. Dis. J. 2010 Jul;29(7):618-23.
• 2010
  Taha MK, Deghmane AE, Impact of changing epidemiology on vaccination strategies in Africa, Future Microbiol 2010 Jun;5(6):837-9.
• 2009
  Deghmane AE, Alonso JM, Taha MK, , Emerging drugs for acute bacterial meningitis., Expert Opin Emerg Drugs 2009 Sep; 14(3): 381-93.
• 2009
  Rameix-Welti MA, Zarantonelli ML, Giorgini D, Ruckly C, Marasescu M, van der Werf S, Alonso JM, Naffakh N, Taha MK, , Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules., Infect Immun 2009 Sep; 77(9): 3588-95.
• 2009
  Murphy E, Andrew L, Lee KL, Dilts DA, Nunez L, Fink PS, Ambrose K, Borrow R, Findlow J, Taha MK, Deghmane AE, Kriz P, Musilek M, Kalmusova J, Caugant DA, Alvestad T, Mayer LW, Sacchi CT, Wang X, Martin D, von Gottberg A, du Plessis M, Klugman KP, Anderson AS, Jansen KU, Zlotnick GW, Hoiseth SK, Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis, J. Infect. Dis. 2009 Aug;200(3):379-89.
• 2009
  Poncet S, Milohanic E, Mazé A, Nait Abdallah J, Aké F, Larribe M, Deghmane AE, Taha MK, Dozot M, De Bolle X, Letesson JJ, Deutscher J, Correlations between carbon metabolism and virulence in bacteria, Contrib Microbiol 2009;16:88-102.
• 2009
  Skoczynska A, Ruckly C, Hong E, Taha MK, Molecular characterization of resistance to rifampicin in clinical isolates of Neisseria meningitidis, Clin. Microbiol. Infect. 2009 Dec;15(12):1178-81.
• 2009
  Deghmane AE, Veckerlé C, Giorgini D, Hong E, Ruckly C, Taha MK, , Differential modulation of TNF-alpha-induced apoptosis by Neisseria meningitidis., PLoS Pathog 2009 May; 5(5): e1000405.
• 2008
  Taha MK, Alonso JM, , [Anti-meningococcal vaccines]., Rev Prat 2008 Dec; 58(19): 2099-101.
• 2008
  Levy C, Taha MK, Weill Olivier C, Quinet B, Lécuyer A, Alonso JM, Cohen R, Bingen E, , [Characteristics of meningococcal meningitis in children in France], Arch Pediatr 2008 Dec;15 Suppl 3:S105-10.
• 2008
  Skoczynska A, Alonso JM, Taha MK, Ciprofloxacin resistance in Neisseria meningitidis, France, Emerging Infect. Dis. 2008 Aug;14(8):1322-3.
• 2008
  Taha MK, Alonso JM, Corticosteroids for bacterial meningitis, N. Engl. J. Med. 2008 Mar;358(13):1400; author reply 1400-1.
• 2008
  Zarantonelli ML, Lancellotti M, Deghmane AE, Giorgini D, Hong E, Ruckly C, Alonso JM, Taha MK, Hyperinvasive genotypes of Neisseria meningitidis in France, Clin. Microbiol. Infect. 2008 May;14(5):467-72.
• 2008
  Ferreira E, Dias R, Giorgini D, Caniça M, Taha MK, Neisseria meningitidis serogroup W135 in Portugal: presence of the ST-11/ET-37 clonal complex, Pathol. Biol. 2008 Mar;56(2):94-6.
• 2007
  Taha MK, Alonso JM, , Molecular epidemiology of infectious diseases: the example of meningococcal disease., Res Microbiol ; 159(1): 62-6.
• 2007
  Zarantonelli ML, Szatanik M, Giorgini D, Hong E, Huerre M, Guillou F, Alonso JM, Taha MK, , Transgenic mice expressing human transferrin as a model for meningococcal infection., Infect Immun 2007 Dec; 75(12): 5609-14.
• 2007
  Taha MK, Vázquez JA, Hong E, Bennett DE, Bertrand S, Bukovski S, Cafferkey MT, Carion F, Christensen JJ, Diggle M, Edwards G, Enríquez R, Fazio C, Frosch M, Heuberger S, Hoffmann S, Jolley KA, Kadlubowski M, Kechrid A, Kesanopoulos K, Kriz P, Lambertsen L, Levenet I, Musilek M, Paragi M, Saguer A, Skoczynska A, Stefanelli P, Thulin S, Tzanakaki G, Unemo M, Vogel U, Zarantonelli ML, , Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis., Antimicrob Agents Chemother 2007 Aug; 51(8): 2784-92.
• 2007
  Parent du Châtelet I, Taha MK, Sesboüé C, Rouaud P, Perrocheau A, Lévy-Bruhl D, [Increased incidence of invasive meningococcal disease in Seine-Maritime. The evolving epidemiology due to the B:14:P1.7,16 strain], Arch Pediatr 2007 Jun;14(6):537-40.
• 2007
  Elias J, Reinhardt M, Hautmann W, Harms I, Oppermann H, Schröter M, Hellenbrand W, Oster P, Kurzai O, Taha MK, Nossal R, Frosch M, Vogel M, [3rd Workshop on Epidemiology, Prevention and Treatment of Invasive Meningococcal Disease in Würzburg 2006], Gesundheitswesen 2007 Apr;69(4):256-62.
• 2007
  Taha MK, Alonso JM, , Meningococcal vaccines: to eradicate the disease, not the bacterium., Hum Vaccin ; 3(4): 149-52.
• 2007
  Boisier P, Nicolas P, Djibo S, Taha MK, Jeanne I, Maïnassara HB, Tenebray B, Kairo KK, Giorgini D, Chanteau S, Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger, Clin. Infect. Dis. 2007 Mar;44(5):657-63.
• 2007
  Taha MK, Fox A, , Quality assessed nonculture techniques for detection and typing of meningococci., FEMS Microbiol Rev 2007 Jan; 31(1): 37-42.
• 2006
  Fox AJ, Taha MK, Vogel U, Standardized nonculture techniques recommended for European reference laboratories, FEMS Microbiol. Rev. 2007 Jan;31(1):84-8.
• 2006
  Zarantonelli ML, Huerre M, Taha MK, Alonso JM, , Differential role of lipooligosaccharide of Neisseria meningitidis in virulence and inflammatory response during respiratory infection in mice., Infect Immun 2006 Oct; 74(10): 5506-12.
• 2006
  Traoré Y, Njanpop-Lafourcade BM, Adjogble KL, Lourd M, Yaro S, Nacro B, Drabo A, Parent du Châtelet I, Mueller JE, Taha MK, Borrow R, Nicolas P, Alonso JM, Gessner BD, The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005, Clin. Infect. Dis. 2006 Oct;43(7):817-22.
• 2006
  Rouaud P, Perrocheau A, Taha MK, Sesboué C, Forgues AM, Parent du Châtelet I, Levy-Bruhl D, Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005, Euro Surveill. 2006 Jul;11(7):178-81.
• 2006
  Rouaud P, Perrocheau A, Taha MK, Sesboué C, Forgues AM, Parent du Châtelet I, Lévy-Bruhl D, Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005, Euro Surveill. 2006 Jul;11(7):3-4.
• 2006
  Taha MK, Zarantonelli ML, Ruckly C, Giorgini D, Alonso JM, Rifampin-resistant Neisseria meningitidis, Emerging Infect. Dis. 2006 May;12(5):859-60.
• 2006
  Zarantonelli ML, Antignac A, Lancellotti M, Guiyoule A, Alonso JM, Taha MK, , Immunogenicity of meningococcal PBP2 during natural infection and protective activity of anti-PBP2 antibodies against meningococcal bacteraemia in mice., J Antimicrob Chemother 2006 May; 57(5): 924-30.
• 2006
  Taha MK, Zarantonelli ML, Neri A, Enriquez R, Vázquez JA, Stefanelli P, , Interlaboratory comparison of PCR-based methods for detection of penicillin G susceptibility in Neisseria meningitidis., Antimicrob Agents Chemother 2006 Mar; 50(3): 887-92.
• 2006
  Taha MK, Zarantonelli ML, Alonso JM, Naess LM, Holst J, Feiring B, Rosenqvist E, Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks, Vaccine 2007 Mar;25(14):2537-8.
• 2005
  Perrocheau A, Taha MK, Levy-Bruhl D, Epidemiology of invasive meningococcal disease in France in 2003, Euro Surveill. 2005 Dec;10(12):238-41.
• 2005
  Perrocheau A, Taha MK, Lévy-Bruhl D, Epidemiology of invasive meningococcal disease in France in 2003, Euro Surveill. 2005 Dec;10(12):9-10.
• 2005
  Touqui L, Paya M, Thouron F, Guiyoule A, Zarantonelli ML, Leduc D, Wu Y, Taha MK, Alonso JM, , Neisseria meningitidis pili induce type-IIA phospholipase A2 expression in alveolar macrophages., FEBS Lett 2005 Sep; 579(22): 4923-7.
• 2005
  Lancellotti M, Guiyoule A, Ruckly C, Hong E, Alonso JM, Taha MK, , Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37/ST-11 clonal complex., Microbes Infect 2006 Jan; 8(1): 191-6.
• 2005
  Taha MK, Alonso JM, [Pathophysiology and molecular pathogenesis of meningococcal invasive infections], Arch Pediatr 2005 Jun;12(6):753-4.
• 2005
  Alonso JM, Taha MK, , [Meningococcal vaccines: present status and perspectives]., Therapie. 2005 ; 60(3): 283-6.
• 2005
  Holst J, Feiring B, Naess LM, Norheim G, Kristiansen P, Høiby EA, Bryn K, Oster P, Costantino P, Taha MK, Alonso JM, Caugant DA, Wedege E, Aaberge IS, Rappuoli R, Rosenqvist E, The concept of “tailor-made”, protein-based, outer membrane vesicle vaccines against meningococcal disease, Vaccine 2005 Mar;23(17-18):2202-5.
• 2005
  Njanpop-Lafourcade BM, Parent du Châtelet I, Sanou O, Alonso JM, Taha MK, The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso, Microbes Infect. 2005 Apr;7(4):645-9.
• 2005
  Faye A, Mariani-Kurkjian P, Taha MK, Louzeau C, Bingen E, Bourrillon A, [Clinical aspects and outcome of meningococcal disease due to Neisseria meningitidis of serogroup W135 in 5 children], Arch Pediatr 2005 Mar;12(3):291-4.
• 2005
  Taha MK, Alonso JM, Cafferkey M, Caugant DA, Clarke SC, Diggle MA, Fox A, Frosch M, Gray SJ, Guiver M, Heuberger S, Kalmusova J, Kesanopoulos K, Klem AM, Kriz P, Marsh J, Mölling P, Murphy K, Olcén P, Sanou O, Tzanakaki G, Vogel U, , Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis., J Clin Microbiol 2005 Jan; 43(1): 144-9.
• 2004
  Parent du Châtelet I, Traore Y, Gessner BD, Antignac A, Naccro B, Njanpop-Lafourcade BM, Ouedraogo MS, Tiendrebeogo SR, Varon E, Taha MK, Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing, Clin. Infect. Dis. 2005 Jan;40(1):17-25.
• 2004
  Taha MK, Olcén P, , Molecular genetic methods in diagnosis and direct characterization of acute bacterial central nervous system infections., APMIS ; 112(11-12): 753-70.
• 2004
  Taha MK, Giorgini D, Ducos-Galand M, Alonso JM, , Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000., J Clin Microbiol 2004 Sep; 42(9): 4158-63.
• 2004
  Grodet C, Dequin PF, Watt S, Lanotte P, de Gialluly C, Taha MK, Alonso JM, Quentin R, Goudeau A, Mereghetti L, Outbreak in France of Neisseria meningitidis B:15:P1.12 belonging to sequence type 1403, Clin. Microbiol. Infect. 2004 Sep;10(9):845-8.
• 2004
  Deghmane AE, Giorgini D, Maigre L, Taha MK, , Analysis in vitro and in vivo of the transcriptional regulator CrgA of Neisseria meningitidis upon contact with target cells., Mol Microbiol 2004 Aug; 53(3): 917-27.
• 2004
  Bay S, Huteau V, Zarantonelli ML, Pires R, Ughetto-Monfrin J, Taha MK, England P, Lafaye P, , Phosphorylcholine-carbohydrate-protein conjugates efficiently induce hapten-specific antibodies which recognize both Streptococcus pneumoniae and Neisseria meningitidis: a potential multitarget vaccine against respiratory infections., J Med Chem 2004 Jul; 47(16): 3916-9.
• 2004
  Faye A, Marianni-Kurkdjian P, Taha MK, Soussan V, Bingen E, Bourrillon A, [Meningococcal disease due to Neisseria meningitidis serogroup W135 in children. Clinical aspects and outcome], Presse Med 2004 Jun;33(10):654-7.
• 2004
  Faye A, Mariani-Kurkdjian P, Taha MK, Angoulvant F, Antonios M, Aubertin G, Soussan V, Bingen E, Bourrillon A, Clinical features and outcome of pediatric Neisseria meningitidis serogroup W135 infection: a report of 5 cases, Clin. Infect. Dis. 2004 Jun;38(11):1635-7.
• 2003
  Vienne P, Ducos-Galand M, Guiyoule A, Pires R, Giorgini D, Taha MK, Alonso JM, , The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia., Clin Infect Dis 2003 Dec; 37(12): 1639-42.
• 2003
  Sidikou F, Djibo S, Taha MK, Alonso JM, Djibo A, Kairo KK, Chanteau S, Boisier P, Polymerase chain reaction assay and bacterial meningitis surveillance in remote areas, Niger, Emerging Infect. Dis. 2003 Nov;9(11):1486-8.
• 2003
  Alonso JM, Taha MK, [Respiratory virosis and invasive bacterial superinfections. The case for influenza and meningococcal diseases], Arch Pediatr 2003 Nov;10(11):1013-5.
• 2003
  Vázquez JA, Arreaza L, Block C, Ehrhard I, Gray SJ, Heuberger S, Hoffmann S, Kriz P, Nicolas P, Olcen P, Skoczynska A, Spanjaard L, Stefanelli P, Taha MK, Tzanakaki G, Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections, Antimicrob. Agents Chemother. 2003 Nov;47(11):3430-4.
• 2003
  Zarantonelli ML, Carlier JP, Alonso JM, Taha MK, , Insertional inactivation of the lpxA gene involved in the biosynthesis of lipid A in Neisseria meningitidis resulted in lpxA/lpxA::aph-3′ heterodiploids., FEMS Microbiol Lett 2003 Sep; 226(1): 51-6.
• 2003
  Antignac A, Ducos-Galand M, Guiyoule A, Pirès R, Alonso JM, Taha MK, , Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns., Clin Infect Dis 2003 Oct; 37(7): 912-20.
• 2003
  Antignac A, Rousselle JC, Namane A, Labigne A, Taha MK, Boneca IG, , Detailed structural analysis of the peptidoglycan of the human pathogen Neisseria meningitidis., J Biol Chem 2003 Aug; 278(34): 31521-8.
• 2003
  Antignac A, Boneca IG, Rousselle JC, Namane A, Carlier JP, Vázquez JA, Fox A, Alonso JM, Taha MK, , Correlation between alterations of the penicillin-binding protein 2 and modifications of the peptidoglycan structure in Neisseria meningitidis with reduced susceptibility to penicillin G., J Biol Chem 2003 Aug; 278(34): 31529-35.
• 2003
  Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jéhanno M, Viala J, Tedin K, Taha MK, Labigne A, Zähringer U, Coyle AJ, DiStefano PS, Bertin J, Sansonetti PJ, Philpott DJ, , Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan., Science 2003 Jun; 300(5625): 1584-7.
• 2003
  Alonso JM, Guiyoule A, Zarantonelli ML, Ramisse F, Pires R, Antignac A, Deghmane AE, Huerre M, van der Werf S, Taha MK, , A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice., FEMS Microbiol Lett 2003 May; 222(1): 99-106.
• 2003
  Deghmane AE, Larribe M, Giorgini D, Sabino D, Taha MK, , Differential expression of genes that harbor a common regulatory element in Neisseria meningitidis upon contact with target cells., Infect Immun 2003 May; 71(5): 2897-901.
• 2003
  Deghmane AE, Taha MK, , The Neisseria meningitidis adhesion regulatory protein CrgA acts through oligomerization and interaction with RNA polymerase., Mol Microbiol 2003 Jan; 47(1): 135-43.
• 2003
  Boël G, Mijakovic I, Mazé A, Poncet S, Taha MK, Larribe M, Darbon E, Khemiri A, Galinier A, Deutscher J, Transcription regulators potentially controlled by HPr kinase/phosphorylase in Gram-negative bacteria, J. Mol. Microbiol. Biotechnol. 2003;5(4):206-15.
• 2002
  du Châtelet IP, Alonso JM, Taha MK, [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt], Bull Soc Pathol Exot 2002 Dec;95(5):323-4; discussion 324-5.
• 2002
  Taha MK, Deghmane AE, Antignac A, Zarantonelli ML, Larribe M, Alonso JM, , The duality of virulence and transmissibility in Neisseria meningitidis., Trends Microbiol 2002 Aug; 10(8): 376-82.
• 2002
  Lévy-Bruhl D, Perrocheau A, Mora M, Taha MK, Dromell-Chabrier S, Beytout J, Quatresous I, Vaccination campaign following an increase in incidence of serogroup C meningococcal diseases in the department of Puy-de-Dôme (France), Euro Surveill. 2002 May;7(5):74-6.
• 2002
  Taha MK, , Molecular detection and characterization of Neisseria meningitidis., Expert Rev Mol Diagn 2002 Mar; 2(2): 143-50.
• 2002
  Taha MK, Parent Du Chatelet I, Schlumberger M, Sanou I, Djibo S, de Chabalier F, Alonso JM, , Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger., J Clin Microbiol 2002 Mar; 40(3): 1083-4.
• 2001
  Antignac A, Kriz P, Tzanakaki G, Alonso JM, Taha MK, Polymorphism of Neisseria meningitidis penA gene associated with reduced susceptibility to penicillin, J. Antimicrob. Chemother. 2001 Mar;47(3):285-96.
• 2000
  Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, Fox A, Gray S, Kaczmarski E, Serogroup W135 meningococcal disease in Hajj pilgrims, Lancet 2000 Dec 23-30;356(9248):2159.
• 2000
  Deghmane AE, Petit S, Topilko A, Pereira Y, Giorgini D, Larribe M, Taha MK, Intimate adhesion of Neisseria meningitidis to human epithelial cells is under the control of the crgA gene, a novel LysR-type transcriptional regulator, EMBO J. 2000 Mar;19(5):1068-78.
• 2000
  Taha MK, Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis, J. Clin. Microbiol. 2000 Feb;38(2):855-7.
• 2000
  Taha MK, Neisseria meningitidis induces the expression of the TNF-alpha gene in endothelial cells, Cytokine 2000 Jan;12(1):21-5.
• 1999
  Kriz P, Giorgini D, Musilek M, Larribe M, Taha MK, Microevolution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech Republic, Res. Microbiol. 1999 May;150(4):273-80.
• 1998
  Taha MK, Morand PC, Pereira Y, Eugène E, Giorgini D, Larribe M, Nassif X, Pilus-mediated adhesion of Neisseria meningitidis: the essential role of cell contact-dependent transcriptional upregulation of the PilC1 protein, Mol. Microbiol. 1998 Jun;28(6):1153-63.
• 1998
  Musilek M, Giorgini D, Hamadouche N, Kriz P, Taha MK, Genetic heterogeneity of strains of Neisseria meningitidis belonging to serotype 22 isolated in the Czech Republic, J. Clin. Microbiol. 1998 Feb;36(2):563-5.
• 1997
  Pron B, Taha MK, Rambaud C, Fournet JC, Pattey N, Monnet JP, Musilek M, Beretti JL, Nassif X, Interaction of Neisseria maningitidis with the components of the blood-brain barrier correlates with an increased expression of PilC, J. Infect. Dis. 1997 Nov;176(5):1285-92.
• 1997
  Giorgini D, Nassif X, Taha MK, [Rapid epidemiological characterization of Neisseria meningitidis using polymerization chain reaction from biological samplings], Presse Med 1997 Oct;26(32):1516-9.
• 1997
  Nassif X, Marceau M, Pujol C, Pron B, Beretti JL, Taha MK, Type-4 pili and meningococcal adhesiveness, Gene 1997 Jun;192(1):149-53.
• 1997
  De Reuse H, Taha MK, RegF, an SspA homologue, regulates the expression of the Neisseria gonorrhoeae pilE gene, Res. Microbiol. 1997 May;148(4):289-303.
• 1997
  Larribe M, Taha MK, Topilko A, Marchal C, Control of Neisseria gonorrhoeae pilin gene expression by environmental factors: involvement of the pilA/pilB regulatory genes, Microbiology (Reading, Engl.) 1997 May;143 ( Pt 5):1757-64.
• 1997
  Guibourdenche M, Giorgini D, Guèye A, Larribe M, Riou JY, Taha MK, Genetic analysis of a meningococcal population based on polymorphism of the pilA-pilB locus: a molecular approach for meningococcal epidemiology, J. Clin. Microbiol. 1997 Mar;35(3):745-50.
• 1996
  Taha MK, Giorgini D, Nassif X, The pilA regulatory gene modulates the pilus-mediated adhesion of Neisseria meningitidis by controlling the transcription of pilC1, Mol. Microbiol. 1996 Mar;19(5):1073-84.
• 1995
  Giorgini D, Taha MK, Molecular typing of Neisseria meningitidis serogroup A using the polymerase chain reaction and restriction endonuclease pattern analysis, Mol. Cell. Probes 1995 Oct;9(5):297-306.
• 1995
  Taha MK, Giorgini D, Phosphorylation and functional analysis of PilA, a protein involved in the transcriptional regulation of the pilin gene in Neisseria gonorrhoeae, Mol. Microbiol. 1995 Feb;15(4):667-77.
• 1992
  Taha MK, Larribe M, Dupuy B, Giorgini D, Marchal C, Role of pilA, an essential regulatory gene of Neisseria gonorrhoeae, in the stress response, J. Bacteriol. 1992 Sep;174(18):5978-81.
• 1991
  Dupuy B, Taha MK, Pugsley AP, Marchal C, Neisseria gonorrhoeae prepilin export studied in Escherichia coli, J. Bacteriol. 1991 Dec;173(23):7589-98.
• 1991
  Marchal C, Taha MK, Larribe M, Seifert HS, So M, [Molecular bases of virulence in Neisseria gonorrhoeae], Bull. Acad. Natl. Med. 1991 Jun-Jul;175(6):823-34.
• 1991
  Taha MK, Dupuy B, Saurin W, So M, Marchal C, Control of pilus expression in Neisseria gonorrhoeae as an original system in the family of two-component regulators, Mol. Microbiol. 1991 Jan;5(1):137-48.
• 1990
  Taha MK, Marchal C, Conservation of Neisseria gonorrhoeae pilus expression regulatory genes pilA and pilB in the genus Neisseria, Infect. Immun. 1990 Dec;58(12):4145-8.
• 1988
  Taha MK, So M, Seifert HS, Billyard E, Marchal C, Pilin expression in Neisseria gonorrhoeae is under both positive and negative transcriptional control, EMBO J. 1988 Dec;7(13):4367-78.
• 1980
  Briggs BA, , Perioperative cardiovascular morbidity and mortality., Int Anesthesiol Clin 1980 ; 18(3): 71-83.